Abstract
Pancreatic Cancer has the lowest survival rate in 5 years (8%) among all types of Cancer and is expected to become the second leading cause of Cancer death by 2030. In this scenario, we propose to evaluate the frequency and the spectrum of germline mutations in genes predisposing to Cancer in patients with Pancreatic Cancer; (ii) investigate lifestyle and family history; and (iii) develop…